Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company's indirect wholly owned subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd., it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in China. As of June 30, 2013, the Company is manufacturing a range of 58 products approved by the China Food and Drug Administration (CFDA), 24 of which are listed in the National Medical Reimbursement List (NMRL) and 10 are listed in the Essential Drug List (EDL) of the China. The Company's medicines are used in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, dermatology, pediatrics, gastroenterology and orthopedics. The Company markets its products through regional distributors, as well as directly to the hospitals, clinics and pharmacies.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NYSEMKT:TPI
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $0.16
- 200 Day Moving Avg: $0.16
- 52 Week Range: $0.12 - $0.18
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Net Margins: -31.28%
- Return on Equity: -5.17%
- Return on Assets: -4.91%
Frequently Asked Questions for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
What is Tianyin Pharmaceutical Inc Co's stock symbol?
Tianyin Pharmaceutical Inc Co trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "TPI."
Where is Tianyin Pharmaceutical Inc Co's stock going? Where will Tianyin Pharmaceutical Inc Co's stock price be in 2017?
1 equities research analysts have issued twelve-month price targets for Tianyin Pharmaceutical Inc Co's stock. Their forecasts range from $23.00 to $23.00. On average, they expect Tianyin Pharmaceutical Inc Co's stock price to reach $23.00 in the next year. View Analyst Ratings for Tianyin Pharmaceutical Inc Co.
Who are some of Tianyin Pharmaceutical Inc Co's key competitors?
Some companies that are related to Tianyin Pharmaceutical Inc Co include British American Tobacco PLC (BTI), Imperial Oil Ltd (IMO), Straight Path Communications (STRP), Globalstar (GSAT), Grupo Simec SAB de CV (SIM), SRC Energy (SRCI), Park National (PRK), NovaGold Resources (NG), TherapeuticsMD (TXMD), Sandstorm Gold Ltd (SAND), Chase (CCF), National HealthCare (NHC), Gorman-Rupp Co (GRC), Klondex Mines Ltd (KLDX), Gold Standard Ventures Corp (GSV), Northern Dynasty Minerals Ltd (NAK), Taseko Mines Ltd (TGB) and BioTime (BTX).
Who are Tianyin Pharmaceutical Inc Co's key executives?
Tianyin Pharmaceutical Inc Co's management team includes the folowing people:
- Guoqing Jiang, Chairman of the Board, President, Chief Executive Officer, Acting Chief Financial Officer
- Tao Yang, Chief Operating Officer
- Xintao You, Chief Technology Officer
- Daqiao Zhang, Vice President - Marketing and Sales
- Jianping Hou Ph.D., Independent Director
- Zhan Yong, Independent Director
- Zunjian Zhang Ph.D., Independent Director
How do I buy Tianyin Pharmaceutical Inc Co stock?
Shares of Tianyin Pharmaceutical Inc Co can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tianyin Pharmaceutical Inc Co's stock price today?
MarketBeat Community Rating for Tianyin Pharmaceutical Inc Co (NYSEMKT TPI)MarketBeat's community ratings are surveys of what our community members think about Tianyin Pharmaceutical Inc Co and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Tianyin Pharmaceutical Inc Co stock can currently be purchased for approximately $0.16.
Consensus Ratings for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$23.00|
Analysts' Ratings History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
(Data available from 9/25/2015 forward)
|1/17/2017||Roth Capital||Initiated Coverage||Buy||$23.00|
Earnings History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)Earnings History by Quarter for Tianyin Pharmaceutical Inc Co (NYSEMKT TPI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/14/2013||Q1||$0.05||$15.97 million||$14.75 million||View||N/A|
|2/14/2013||Q2 2013||$0.06||$18.20 million||$17.60 million||View||N/A|
Earnings Estimates for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)Insider Trades by Quarter for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/3/2014||Guoqing Jiang||CEO||Buy||23,725||$0.68||$16,133.00|| |
|5/28/2014||James Jiayuan Tong||CFO||Buy||5,000||$0.68||$3,400.00|| |
|3/11/2014||James Jiayuan Tong||CFO||Buy||3,000||$1.07||$3,210.00|| |
|6/26/2013||James Jiayuan Tong||CFO||Buy||8,600||$0.49||$4,214.00|| |
|3/28/2013||James Jiayuan Tong||CFO||Buy||56,500||$0.08||$4,520.00|| |
Headline Trends for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
Latest Headlines for Tianyin Pharmaceutical Inc Co (NYSEMKT:TPI)
|Tianyin Pharmaceutical (TPI) Receiving Somewhat Critical Media Coverage, Analysis Shows|
www.americanbankingnews.com - May 3 at 8:56 AM
|Tianyin Pharmaceutical (TPI) Receives Daily Media Impact Rating of -0.20|
www.americanbankingnews.com - April 18 at 8:34 AM
|8 IPO Hopefuls for Week of July 18|
247wallst.com - July 18 at 9:25 AM
|NYSE prepares to delist Tianyin Pharma over failure to file financials|
seekingalpha.com - May 7 at 2:51 PM
|Tianyin Pharmaceutical Co., Inc. (TPI)|
finance.yahoo.com - February 18 at 12:54 PM
|Worst Performing Industries For February 3, 2016|
feeds.benzinga.com - February 3 at 12:33 PM
|Tianyin Pharmaceutical Co., Inc.|
biz.yahoo.com - January 21 at 12:33 PM
|TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a Continued Listing|
biz.yahoo.com - January 11 at 4:39 PM
|TPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing Requirements|
finance.yahoo.com - January 11 at 4:05 PM
|TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events|
biz.yahoo.com - December 23 at 2:27 PM
|TIANYIN PHARMACEUTICAL CO., INC. Financials|
finance.yahoo.com - December 8 at 1:15 PM
|TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru|
biz.yahoo.com - December 2 at 4:06 PM
|TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements|
finance.yahoo.com - December 2 at 4:05 PM
|TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events|
biz.yahoo.com - October 16 at 10:28 AM
|TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 10-Q/A, Quarterly Report|
biz.yahoo.com - August 20 at 10:58 AM
|TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review|
biz.yahoo.com - August 11 at 6:21 AM
|TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements|
finance.yahoo.com - July 30 at 4:05 PM